Results 51 to 60 of about 10,309 (205)

Addressing Social and Cultural Determinants of Health for Aboriginal and Torres Strait Islander People in Chronic Disease Programs: A Scoping Review

Health Promotion Journal of Australia, Volume 36, Issue 4, October 2025.
ABSTRACT Objective This research aimed to assess, synthesise and analyse the evidence to understand whether chronic disease programmes for Aboriginal and Torres Strait Islander peoples address social and cultural health determinants and what strategies are being used to achieve them.
Petra Mossop, Uday Narayan Yadav, Rosemary Wyber, Julieann Coombes, Kirsty Douglas   +4 more
wiley   +1 more source

Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly

Drugs in R&D, 2018
Background and Objectives Management of hypertension and dyslipidemia is important when considering cardiovascular disease risk; however, achievement of optimal lipid and blood pressure (BP) targets in clinical practice remains inadequate.
John S. Sampalis, Eliofotisti Psaradellis, Melissa Stutz, Jenaya Rickard, Emmanouil Rampakakis   +4 more
doaj   +1 more source

Therapeutic Plasma Exchange Shows Greater Efficacy Than DFPP in Reducing FT3 and FT4 Levels in Thyrotoxicosis due to Amiodarone‐Induced Thyrotoxicosis Type 2

Journal of Clinical Apheresis, Volume 40, Issue 5, October 2025.
ABSTRACT The American Society for Apheresis (ASFA) recommendations only mention using therapeutic plasma exchange (TPE) to treat drug‐resistant thyroid storms. Double filtration plasmapheresis (DFPP) is a therapeutic apheresis procedure with the advantage of being semi‐selective, making it possible to limit albumin losses and reduce the volume of ...
Marion Gerbal, Olivier Gilly, Marie‐Alix Joyeux, Olivier Moranne   +3 more
wiley   +1 more source

Clinical and pharmaco-economic assessment of ACE inhibitors perindopril and enalapril in coronary heart disease patients after coronary artery bypass graft surgery

Кардиоваскулярная терапия и профилактика, 2009
Aim. To perform clinical and pharmaco-economic assessment of long-term therapy with ACE inhibitors perindopril and enalapril in coronary heart disease (CHD) patients after coronary artery bypass graft (CABG) surgery.Material and methods. This prospective,
Yu. M. Lopatin, E. P. Dronova
doaj  

Medication‐Related Osteonecrosis of the Jaws in Patients on Antiresorptive Medication With Dental Implants. A Scoping Review

Clinical Oral Implants Research, Volume 36, Issue 10, Page 1173-1201, October 2025.
ABSTRACT Objectives Patients receiving antiresorptive medication (AR) for osteoporosis or cancer are at risk of medication‐related osteonecrosis of the jaws (MRONJ), especially after surgical procedures. Dental implant (DI) placement in high‐dose AR (HDAR) patients is widely discouraged, and thorough counseling is recommended for low‐dose AR (LDAR ...
Sanne Werner Moeller Andersen, Nishma Vandvig Hindocha, Iben Poulsen, Henning Schliephake, Simon Storgård Jensen   +4 more
wiley   +1 more source

COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH

Рациональная фармакотерапия в кардиологии, 2017
Aim. To study the efficacy and safety of the use of combined antihypertensive therapy with perindopril (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid-lowering therapy with rosuvastatin, and to assess the ...
O. M. Drapkina
doaj   +1 more source

Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling

Frontiers in Pharmacology, 2020
Left ventricular hypertrophy (LVH) is an important characteristic of hypertensive heart disease. Renin-angiotensin system (RAS) blockers have been shown to be effective drugs for the reversal of LVH.
Xiaotong Song, Xiaotong Song, Yue Zhao, Shijun Wang, Shijun Wang, Yuan Wang, Yuan Wang, Qian Chen, Qian Chen, Haijun Zhao, Haijun Zhao, Hua Wang, Sheng Tian, Sheng Tian, Huayun Yu, Huayun Yu, Zhichun Wu, Zhichun Wu   +17 more
doaj   +1 more source

Moderate intermittent hypoxic conditioning to enhance vascular function and cardiorespiratory fitness in the elderly: A randomized controlled trial

Physiological Reports, Volume 13, Issue 19, October 2025.
Abstract Vascular aging involves reduced endothelial function, a key factor in cardiovascular diseases. Intermittent hypoxia may improve endothelial function and cardiorespiratory fitness (CRF), but its effects in elderly individuals, especially in the mid‐term, have not yet been studied.
Hugo Randy, Titouan P. Perrin, Abdallah Ghaith, Dario Kohlbrenner, Patrice Flore, Benoit Champigneulle, Michel Guinot, Stéphane Doutreleau, Julien Brugniaux, Samuel Verges, Mathieu Marillier   +10 more
wiley   +1 more source

Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis

Frontiers in Physiology, 2019
Objective: Ventricular remodeling is considered the basis of heart failure and is involved in myocardial fibrosis. This study aimed to assess perindopril and a galectin-3 inhibitor (modified citrus pectin, MCP) for their effects on ventricular remodeling
Sha Li, Shuren Li, Xiao Hao, Yuehua Zhang, Wenhao Deng   +4 more
doaj   +1 more source

Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high‐dose insulin therapy

British Journal of Clinical Pharmacology, Volume 91, Issue 9, Page 2613-2620, September 2025.
Aims Amlodipine poisoning is a leading cause of cardiovascular medication‐related deaths, commonly managed with high‐dose insulin (HDI) therapy. However, HDI is a vasodilator that is counterproductive in managing vasoplegia. We aim to study HDI therapy in patients with hypotension following dihydropyridine calcium channel antagonist (CCA) overdose ...
Betty S. H. Chan, Katherine Z. Isoardi, Darren M. Roberts, Ong Sook Har   +3 more
wiley   +1 more source